Cumberland Pharmaceuticals Inc. - Form 8-K Summary
Business Context and Reporting Period
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) filed this Current Report on Form 8-K on November 18, 2025. The filing reports the execution of a material definitive agreement regarding the company's revolving credit facility with Pinnacle Bank.
Key Financial Metrics and Debt Structure
The filing details the following terms for the amended credit facility:
- Total Aggregate Principal: Up to $25 million (unchanged from prior agreement).
- Available Borrowing: Up to $15 million.
- Expansion Option: The Company retains the right to request an increase of up to an additional $10 million.
- Interest Rate: Benchmark Term SOFR plus 2.75%.
- Collateral: Borrowings are secured by substantially all of the Company's assets.
- Maturity Date: Extended to October 1, 2027.
Material Changes Versus Prior Period
The primary material change is the extension of the credit facility's maturity date to October 1, 2027. The aggregate principal funding amount remains unchanged at $25 million. The filing does not provide specific revenue, profit, cash flow, or margin data for the current or prior periods.
Management Commentary, Covenants, and Risks
The amended agreement imposes specific financial covenants and requirements:
- Financial Covenant: Maintenance of a Minimum Fixed Charge Coverage Ratio, determined on a quarterly basis.
- Borrowing Base: Subject to Borrowing Base Requirements as defined in the agreement.
- Contingencies: The filing does not disclose specific unusual items or forward-looking guidance beyond the terms of the credit amendment.
Key Facts for Investor Verification
- Verify the company's current compliance with the Minimum Fixed Charge Coverage Ratio covenant.
- Confirm the current utilization of the $15 million available borrowing capacity.
- Review the specific definition of "Borrowing Base Requirements" in the full agreement to understand potential liquidity constraints.
- Monitor the company's ability to service debt at the new interest rate structure (SOFR + 2.75%).